These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 510089)

  • 1. An enteric-coated pancreatic enzyme preparation that works.
    Graham DY
    Dig Dis Sci; 1979 Dec; 24(12):906-9. PubMed ID: 510089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relations between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts.
    Graham DY
    N Engl J Med; 1977 Jun; 296(23):1314-7. PubMed ID: 16212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effectiveness of a pancreatic enzyme supplement.
    Valerio D; Whyte EH; Schlamm HT; Ruggiero JA; Blackburn GL
    JPEN J Parenter Enteral Nutr; 1981; 5(2):110-4. PubMed ID: 7195437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology for pediatricians. I. Pancreatic enzyme preparations, with special reference to enterically coated microspheres of pancrelipase.
    Cho YW; Aviado DM
    J Clin Pharmacol; 1981; 21(5-6):224-37. PubMed ID: 7021605
    [No Abstract]   [Full Text] [Related]  

  • 6. Pancreatic enzyme replacement therapy in post-pancreatectomy patients.
    Braga M; Cristallo M; De Franchis R; Mangiagalli A; Zerbi A; Agape D; Primignani M; Di Carlo V
    Int J Pancreatol; 1989; 5 Suppl():37-44. PubMed ID: 2702249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
    Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
    J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2-antagonists, and enteric coating.
    Marotta F; O'Keefe SJ; Marks IN; Girdwood A; Young G
    Dig Dis Sci; 1989 Mar; 34(3):456-61. PubMed ID: 2563963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical treatment of pancreatic insufficiency.
    DiMagno EP
    Mayo Clin Proc; 1979 Jul; 54(7):435-42. PubMed ID: 36518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of weight-based dosages of enteric-coated microtablet enzyme preparations in patients with cystic fibrosis.
    Beker LT; Fink RJ; Shamsa FH; Chaney HR; Kluft J; Evans E; Schidlow DV
    J Pediatr Gastroenterol Nutr; 1994 Aug; 19(2):191-7. PubMed ID: 7815242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High- versus low-lipase acid-resistant enzyme preparations in cystic fibrosis: a crossover randomized clinical trial.
    Lancellotti L; Cabrini G; Zanolla L; Mastella G
    J Pediatr Gastroenterol Nutr; 1996 Jan; 22(1):73-8. PubMed ID: 8788291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century.
    Trang T; Chan J; Graham DY
    World J Gastroenterol; 2014 Sep; 20(33):11467-85. PubMed ID: 25206255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
    Löser C; Fölsch UR
    Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pancreatic exocrine deficiency.
    Sarner M
    World J Surg; 2003 Nov; 27(11):1192-5. PubMed ID: 14534818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction of malnutrition and maldigestion with enzyme supplementation in patients with surgical suppression of exocrine pancreatic function.
    Braga M; Cristallo M; De Franchis R; Mangiagalli A; Agape D; Primignani M; Di Carlo V
    Surg Gynecol Obstet; 1988 Dec; 167(6):485-92. PubMed ID: 3187872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic enzyme replacement therapy for people with cystic fibrosis.
    Somaraju UR; Solis-Moya A
    Cochrane Database Syst Rev; 2014 Oct; (10):CD008227. PubMed ID: 25310479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of adequacy of pancreatic enzyme replacement with the multiple-phase carbon-14-triolein test.
    O'Keefe SJ; Adam J
    S Afr Med J; 1984 Nov; 66(20):763-5. PubMed ID: 6208620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential and clinical efficacy of acid-resistant fungal lipase in the treatment of pancreatic steatorrhoea due to cystic fibrosis.
    Zentler-Munro PL; Assoufi BA; Balasubramanian K; Cornell S; Benoliel D; Northfield TC; Hodson ME
    Pancreas; 1992; 7(3):311-9. PubMed ID: 1594552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency.
    Regan PT; Malagelada JR; DiMagno EP; Glanzman SL; Go VL
    N Engl J Med; 1977 Oct; 297(16):854-8. PubMed ID: 20572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis. A controlled study.
    Vyas H; Matthew DJ; Milla PJ
    Eur J Pediatr; 1990 Jan; 149(4):241-3. PubMed ID: 1689245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.